Cancer ruling benefits cheap drugs in India: Experts 2012-03-15 04:59:05

A provision of the Indian Patents Act allows for a compulsory license to be awarded after three years of the grant of patent on drugs that are deemed to be too costly. Other patent rulings are imminent. A long-running case...

Keywords: German drug maker Bayer, compulsory license, cancer drug Glivec, HIV/AIDS drugs

Read More